These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3500754)

  • 1. Response to deoxycoformycin in mature T cell malignancies.
    Ho AD; Stryckmans P; Zittoun R
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1483-4. PubMed ID: 3500754
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane phenotype and response to deoxycoformycin in mature T cell malignancies.
    Dearden CE; Matutes E; Hoffbrand AV; Ganeshaguru K; Brozovic M; Williams HJ; Traub N; Mills M; Linch DC; Catovsky D
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):873-5. PubMed ID: 2890401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
    Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
    Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated pentostatin (2'deoxycoformycin)-induced remissions in a patient with advanced chronic lymphocytic leukemia.
    Dillman RO; Yu AL; Qiao CN
    West J Med; 1988 Mar; 148(3):334-7. PubMed ID: 3259051
    [No Abstract]   [Full Text] [Related]  

  • 6. The activity of deoxycoformycin (pentostatin) in refractory leukemias and lymphomas.
    Spiers AS
    Ann N Y Acad Sci; 1985; 451():138-41. PubMed ID: 3878115
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
    Spiers AS; Parekh SJ
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
    [No Abstract]   [Full Text] [Related]  

  • 8. Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin.
    Brito-Babapulle F; Huang D; Lavender P; Galton D; Catovsky D
    Eur J Haematol; 1988 Feb; 40(2):185-7. PubMed ID: 3257929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effect of deoxycoformycin in human T cell leukemia.
    Yu AL; Kung FH; Bakay B; Nyhan WL
    Adv Exp Med Biol; 1979; 122B():373-9. PubMed ID: 397762
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy.
    Wortmann RL; Holcenberg J; Poplack DG
    Cancer Treat Rep; 1982 Feb; 66(2):387-90. PubMed ID: 6275991
    [No Abstract]   [Full Text] [Related]  

  • 12. T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin).
    Spiers AS; Davis MP; Levine M; Li CY; Mangan KF; Mazza JJ; Neu LT; O'Brien J; Rauch AE; Wiltsie JC
    Scand J Haematol; 1985 Jan; 34(1):57-67. PubMed ID: 2578689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to deoxycoformycin in T cell leukaemias.
    Catovsky D; Dearden C
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):356. PubMed ID: 2894233
    [No Abstract]   [Full Text] [Related]  

  • 14. Deoxycoformycin in the treatment of leukemias and lymphomas.
    Smyth JF; Prentice HG; Proctor S; Hoffbrand AV
    Ann N Y Acad Sci; 1985; 451():123-8. PubMed ID: 3878113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia].
    Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K
    Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia.
    el'Agnaf MR; Ennis KE; Morris TC; Robertson JH; Markey G; Alexander HD
    Br J Haematol; 1986 May; 63(1):93-104. PubMed ID: 2939873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug.
    O'Dwyer PJ; Wagner B; Leyland-Jones B; Wittes RE; Cheson BD; Hoth DF
    Ann Intern Med; 1988 May; 108(5):733-43. PubMed ID: 3282467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
    Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ
    Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382
    [No Abstract]   [Full Text] [Related]  

  • 19. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
    Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.